Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 4Uveal Melanoma 1Sarcoma 1Pleural Neoplasms 1Mediastinal Neoplasms 1Liver Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 359Pemetrexed 275Cisplatin 229Paclitaxel 212Docetaxel 205Gemcitabine 160Erlotinib Hydrochloride 150Bevacizumab 132pembrolizumab 128Radiotherapy 112Nivolumab 88durvalumab 84Drug Therapy 84osimertinib 81atezolizumab 58Vinorelbine 53Gefitinib 53Radiosurgery 49Cetuximab 39Taxes 37130-nm albumin-bound paclitaxel 36Ipilimumab 34anlotinib 33Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 33Etoposide 30Albumin-Bound Paclitaxel 29tislelizumab 27icotinib 27Specimen Handling 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Non-Small-Cell Lung × Ethiodized Oil × Clear all
NCT05672108 2026-03-05

Phase II Trial of Lung Chemoemobolization

City of Hope Medical Center

Phase 2 Recruiting
30 enrolled
GastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Mediastinal Neoplasms, Pleural Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡